Modulation of the Host Cell Transcriptome and Epigenome by Fusobacterium nucleatum.


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
26 10 2021
Historique:
entrez: 27 10 2021
pubmed: 28 10 2021
medline: 4 2 2022
Statut: ppublish

Résumé

Fusobacterium nucleatum is a ubiquitous opportunistic pathogen with an emerging role as an oncomicrobe in colorectal cancer and other cancer settings. F. nucleatum can adhere to and invade host cells in a manner that varies across F. nucleatum strains and host cell phenotypes. Here, we performed pairwise cocultures between three F. nucleatum strains and two immortalized primary host cell types (human colonic epithelial [HCE] cells and human carotid artery endothelial [HCAE] cells) followed by transcriptome sequencing (RNA-seq) and chromatin immunoprecipitation sequencing (ChIP-seq) to investigate transcriptional and epigenetic host cell responses. We observed that F. nucleatum-induced host cell transcriptional modulation involves strong upregulation of genes related to immune migration and inflammatory processes, such as

Identifiants

pubmed: 34700376
doi: 10.1128/mBio.02062-21
pmc: PMC8546542
doi:

Substances chimiques

CCL20 protein, human 0
Chemokine CCL20 0
Dual Oxidases EC 1.11.1.-
DUOX2 protein, human EC 1.6.3.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0206221

Subventions

Organisme : Cancer Research UK
ID : A27140
Pays : United Kingdom
Organisme : CIHR
Pays : Canada

Références

Genome Biol. 2014;15(12):550
pubmed: 25516281
Cancer Res. 2017 Jul 1;77(13):3655-3665
pubmed: 28455419
Infect Immun. 2014 May;82(5):1914-20
pubmed: 24566622
Obstet Gynecol. 2010 Feb;115(2 Pt 2):442-445
pubmed: 20093874
Gut. 2021 Nov;70(11):2123-2137
pubmed: 33318144
Oncotarget. 2015 Feb 28;6(6):4406-17
pubmed: 25726527
Nat Biotechnol. 2010 May;28(5):495-501
pubmed: 20436461
Carcinogenesis. 2017 Aug 1;38(8):781-788
pubmed: 28582482
Oxid Med Cell Longev. 2019 Oct 13;2019:1681972
pubmed: 31737164
DNA Cell Biol. 2020 Jan;39(1):144-151
pubmed: 31765243
Microb Genom. 2020 Feb;6(2):
pubmed: 31661053
Cell Host Microbe. 2013 Aug 14;14(2):195-206
pubmed: 23954158
Front Cell Infect Microbiol. 2017 Jun 30;7:295
pubmed: 28713780
Cell. 2016 Nov 17;167(5):1145-1149
pubmed: 27863232
Front Oncol. 2021 Jul 14;11:691347
pubmed: 34350116
Front Cell Infect Microbiol. 2019 Dec 17;9:429
pubmed: 31921705
Nat Rev Microbiol. 2019 Mar;17(3):156-166
pubmed: 30546113
Oncoimmunology. 2019 Mar 27;8(6):e1581531
pubmed: 31069151
Nat Genet. 2008 Jul;40(7):897-903
pubmed: 18552846
Gastroenterology. 2021 Feb;160(3):797-808.e6
pubmed: 33127391
Int J Cancer. 2017 Dec 15;141(12):2528-2536
pubmed: 28833079
Infect Immun. 2000 Jun;68(6):3140-6
pubmed: 10816455
Gastroenterology. 2017 Mar;152(4):851-866.e24
pubmed: 27876571
Nat Commun. 2020 Jun 26;11(1):3259
pubmed: 32591509
Clin Cancer Res. 2016 Nov 15;22(22):5574-5581
pubmed: 27769987
Sci Rep. 2017 Aug 15;7(1):8265
pubmed: 28811578
Infect Immun. 2004 Apr;72(4):2272-9
pubmed: 15039352
Nature. 2020 Jul;583(7818):744-751
pubmed: 32728240
Genome Res. 2012 Feb;22(2):299-306
pubmed: 22009989
Gut. 2016 Dec;65(12):1973-1980
pubmed: 26311717
Cell. 2000 Oct 13;103(2):311-20
pubmed: 11057903
Gut Pathog. 2020 Sep 29;12:46
pubmed: 33005238
JAMA Oncol. 2015 Aug;1(5):653-61
pubmed: 26181352
J Dig Dis. 2020 Jul;21(7):385-398
pubmed: 32441482
Int J Oncol. 2013 Feb;42(2):549-55
pubmed: 23258614
Front Cell Infect Microbiol. 2020 Aug 07;10:400
pubmed: 32850497
Cell Death Dis. 2018 Mar 2;9(3):355
pubmed: 29500439
Science. 2017 Dec 15;358(6369):1443-1448
pubmed: 29170280
Microbiome. 2013 May 15;1(1):16
pubmed: 24450771
Theranostics. 2020 Jan 1;10(1):323-339
pubmed: 31903123
Clin Microbiol Rev. 1996 Jan;9(1):55-71
pubmed: 8665477
J Exp Med. 2002 Aug 19;196(4):459-68
pubmed: 12186838
Lancet. 2010 Nov 20;376(9754):1741-50
pubmed: 20970847
Cell Host Microbe. 2016 Aug 10;20(2):215-25
pubmed: 27512904
J Exp Clin Cancer Res. 2019 Jan 10;38(1):14
pubmed: 30630498
Nature. 2015 Feb 19;518(7539):317-30
pubmed: 25693563
Nat Biotechnol. 2010 Aug;28(8):817-25
pubmed: 20657582
Nucleic Acids Res. 2020 Jan 8;48(D1):D682-D688
pubmed: 31691826
Gut Microbes. 2011 Sep 1;2(5):294-8
pubmed: 22067936
Anaerobe. 2018 Apr;50:55-59
pubmed: 29409815
PLoS Biol. 2011 Sep;9(9):e1001162
pubmed: 21980263
Clin Oral Investig. 2021 Nov;25(11):6249-6258
pubmed: 33844080
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
Cancer Res. 2016 Oct 1;76(19):5671-5682
pubmed: 27530322
PLoS One. 2013;8(1):e53653
pubmed: 23335968
mBio. 2021 Apr 6;12(2):
pubmed: 33824205
Nat Methods. 2012 Feb 28;9(3):215-6
pubmed: 22373907
Nat Genet. 2007 Mar;39(3):311-8
pubmed: 17277777
Gut. 2011 Jan;60(1):34-40
pubmed: 19926616
Cell. 2017 Jul 27;170(3):548-563.e16
pubmed: 28753429
J Clin Pediatr Dent. 2013 Winter;38(2):155-60
pubmed: 24683780
Cell Host Microbe. 2013 Aug 14;14(2):207-15
pubmed: 23954159
Inflamm Bowel Dis. 2011 Sep;17(9):1971-8
pubmed: 21830275
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
J Clin Periodontol. 1988 May;15(5):316-23
pubmed: 3292595
Periodontol 2000. 1994 Jun;5:66-77
pubmed: 9673163
Sci Rep. 2021 Jan 15;11(1):1608
pubmed: 33452405
Br J Cancer. 2010 Sep 28;103(7):961-9
pubmed: 20808312
Oncol Lett. 2018 Aug;16(2):2606-2612
pubmed: 30013655
Sci Rep. 2016 Sep 28;6:33440
pubmed: 27678333
Ann Oncol. 2020 Oct;31(10):1366-1375
pubmed: 32569727
Infect Immun. 2011 Jul;79(7):2597-607
pubmed: 21536792
Arch Oral Biol. 2020 Apr;112:104669
pubmed: 32028171
Genome Res. 2012 Feb;22(2):292-8
pubmed: 22009990
Infect Immun. 2010 Nov;78(11):4773-8
pubmed: 20823215
Inflamm Bowel Dis. 2014 Mar;20(3):514-24
pubmed: 24492313
Nature. 2021 Apr;592(7852):138-143
pubmed: 33731925
Infect Immun. 2000 Apr;68(4):1893-8
pubmed: 10722579
Immunity. 2015 Feb 17;42(2):344-355
pubmed: 25680274
J Immunother Cancer. 2019 Aug 8;7(1):215
pubmed: 31395078
Sci Signal. 2020 Jul 21;13(641):
pubmed: 32694172
Gut Microbes. 2020 May 3;11(3):511-525
pubmed: 31910722

Auteurs

Cody A Despins (CA)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada.
Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada.

Scott D Brown (SD)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada.

Avery V Robinson (AV)

Molecular and Cellular Biology, University of Guelphgrid.34429.38, Guelph, Ontario, Canada.

Andrew J Mungall (AJ)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada.

Emma Allen-Vercoe (E)

Molecular and Cellular Biology, University of Guelphgrid.34429.38, Guelph, Ontario, Canada.

Robert A Holt (RA)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada.
Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada.
Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH